Disposition and availability of 5-fluorouracil prodrug 5′-deoxy-5-fluorouridine after oral administration in rats
✍ Scribed by J. -Sim Lai Au
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 511 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A gas chromatography-mass spectrometry (GC-MS) method for the simultaneous determination of 5'-deoxy-Sfluorouridine (doxifluridine, 5'-dFUR), 5fluorouracil (5-FU) and its main catabolite 5,6-dihydro-5-fluorouracil (5-FUH\*) in human plasma has been developed. Sample preparation consisted of protein
Dihydro-5-fluorouracluorouracil(5-lWH~) , the maiu catabolite of the anticancer drug 54uorouraeil( WU), can be quantitated iu human serum simultaueously with the pro-drug 5'-deoxy-5-f (5'dFWR), the parent drug 5-PU and the aaabolites 5-fluorouridine and 2'-deoxy-5-f by gradient elution-reversed phas
Oral adminstration of uracil plus ftorafur [ 1-(tetrahydro-2-furanyl)-5-fluorouracil] has a greater antitumor effect than that of ftorafur alone. A high-pressure liquid chromatographic method was developed for the determination of ftorafur in plasma and visceral tissues with a sensitivity of 0.025 l